Search clinical trials for: poor responders

Total 1742 results

Medtronic Bakken Research Center
Medtronic; FRANCE

Completed

Dual-Site LV Pacing in CRT Non Responders: Multicenter Randomized Trial (V3)

Heart Failure

France
Novartis Pharmaceuticals

Withdrawn

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
Dana-Farber Cancer Institute
National Cancer Institute (NCI); Genentech, Inc.

Completed

Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer

Head and Neck Cancer

United States
Ain Shams University
Dar El Teb Institute

Completed

Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?

Infertility
ResMed

Withdrawn

French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS, AirCurve 10CS): Predictive Factors of Poor Compliance (FACE) (FACE)

Heart Failure | Central Sleep Apnea

France
The University of Texas Health Science Center,...
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Interventions for Children With Attention and Reading Disorders (ICARD)

Attention Deficit Hyperactivity Disorder | Reading Disabilities

United States
Hallym University Medical Center

Completed

Practical Advantages of Single-port Over Three-port Laparoscopic Appendectomy in Children (PASTA)

Appendicitis

Korea, Republic of
National University Hospital, Singapore

Completed

SIngle Port vs Standard TEP for Primary Inguinal Hernia Repair (LESSTEP)

Primary Unilateral Inguinal Hernia

Singapore
yangjie

Completed

To Research the Relation Between Neonatal Morbidities and Poor Outcome in Preterm Infants

Outcome, Fatal | Preterm Infant | Morbidity;Infant
Merck Sharp & Dohme LLC

Terminated

Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)

Hepatitis C, Chronic | Insulin Resistance
Washington University School of Medicine

Terminated

4D Phase Contrast MR: Hypertrophy in Liver Cancer

Liver Cancer | Cancer of the Liver

United States
Vanderbilt University Medical Center

Completed

Identification of Inpatients at Risk for Poor Glycemic Control

Hyperglycemia | Hypoglycemia

United States
Vanderbilt University Medical Center
Janssen, LP

Withdrawn

Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment

Treatment Resistant Depression

United States
National Cancer Institute, Naples
Gruppo Oncologico Italia Meridionale; Gruppo Italiano per lo studio dei Carcinomi... and other collaborators

Terminated

CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients (CAPPA-2)

Non-Small Cell Lung Cancer

Italy
Medical University of Vienna

Completed

Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders (NRSily)

Hepatitis C

Austria
National University of Singapore
National University Hospital, Singapore

Unknown

A Nurse-led Smartphone-based Self-management Programme for Type 2 Diabetes Patients With Poor Blood Glucose Control

Type2 Diabetes Mellitus
Ludwig-Maximilians - University of Munich

Terminated

TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion (TOP)

Ischemia Reperfusion Injury | Graft Failure | Graft Dysfunction | Terminal Liver Disease | Poor Graft Quality

Germany
Dalin Tzu Chi General Hospital

Completed

Meperidine for Patients Expected to Have Poor Tolerance During Diagnostic Esophagogastroduodenoscopy.

Patients Undergoing Diagnostic EGD

Taiwan
Massachusetts General Hospital
GlaxoSmithKline

Completed

Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436

Papillary Thyroid Carcinoma

United States
Zimmer Biomet
University of Western Ontario, Canada

Completed

Platelet-Rich and Concentrated Platelet-Poor Plasma to Reduce Air Leak Post-Lobectomy: A Randomized Controlled Trial

Lung Cancer

Canada
Florida State University

Completed

Nighttime Feeding and Morning Endurance Performance

Poor Performance Status

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant (GVHD)

Primary Myelofibrosis | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal... and other conditions

United States
Weill Medical College of Cornell University

Completed

Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML

Myelodysplastic Syndrome

United States
Genelex Corporation
University of Utah

Completed

YouScript IMPACT Registry (IMPACT)

Drug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditions

United States
South Valley University

Completed

Single Incision Versus Three Port Laparoscopic Cholecystectomy

Laparoscopic Cholecystectomy
Dana-Farber Cancer Institute
National Cancer Institute (NCI); Sanofi-Synthelabo

Terminated

Title XELOX FOR SALIVARY GLAND CANCERS

Head and Neck Cancer

United States
University Hospital, Toulouse

Completed

Tolerance of Intranasal Administration of OT in Prader-Willi Newborn Babies (OTBB)

Prader-Willi Syndrome

France
Hospital Clinic of Barcelona
Abbott

Unknown

(MitraClip in Non-Responders to Cardiac Resynchronization Therapy) (MITRA-CRT)

MITRAL REGURGITATION

Spain
Genelex Corporation

Completed

Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM

Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome P450 CYP2C9 Enzyme Deficiency | Cytochrome P450 CYP2C19 Enzyme Deficiency | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | CYP2D6 Polymorphism | Ultrarapid... and other conditions

United States
Air Force Military Medical University, China

Withdrawn

Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis

Liver Cirrhosis | Anticoagulation | Portal Vein Thrombosis
M.D. Anderson Cancer Center
Eli Lilly and Company

Completed

Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer

Lung Cancer

United States
Ain Shams University

Unknown

Sildenafil Citrate of in Vitro Fertilization After Multiple IVF Failures Attributed to Poor Endometrial Development

IVF Failure

Egypt
National Institute of Diabetes and Digestive and...
Bristol-Myers Squibb

Completed

New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C

Hepatitis C | Hepatitis C, Chronic | Cirrhosis | Chronic Hepatitis C

United States
Novartis

Completed

A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients

Hypertension

United States, Germany
Clinical Research Centre, Malaysia
University of Malaya

Completed

Factors Associated With Poor Dengue Outcomes in Malaysia

Dengue Fever

Malaysia
GlaxoSmithKline

Completed

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)

Migraine Disorders

United States
CytoDyn, Inc.

Withdrawn

A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence

HIV

United States
GlaxoSmithKline

Completed

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

Migraine Disorders

United States
Maja Kovacevic, MD

Withdrawn

Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil

Androgenetic Alopecia | Female Pattern Hair Loss

Italy
ANRS, Emerging Infectious Diseases
Bristol-Myers Squibb

Completed

Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)

Hepatitis C Virus Genotype 4 Infection

France
Sun Yat-sen University

Unknown

The Effect of Growth Hormone in Assisted Reproductive Technology Clinical Outcome of Poor Responder

Low Ovarian Reserve
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery

Head and Neck Cancer

United States
London School of Hygiene and Tropical Medicine
Medical Research Council Unit, The Gambia; University of Durham

Completed

A Stitch in Time May Save Lives: Turning Poor Bednets Into Good Ones

Malaria

Gambia
National Institute on Drug Abuse (NIDA)
Wayne State University

Unknown

The Aim of This Study is to Determine the Effectiveness of a Motivational Enhancement Intervention in Reducing Risk Behaviors (Drug and Alcohol Use, Sexual Risk Behavior, Poor Adherence to Medications) Among HIV+ Youth. - 1

Health Behaviors | Adherence | HIV Risk Behaviors | Alcohol & Drug Use | Sexual Risk Behaviors

United States
Sun Yat-sen University

Unknown

Effect of Vision Therapy in Myopic Children With Poor Accommodative Response

Myopia

China
Stony Brook University
National Institute for Occupational Safety and Health (NIOSH/CDC)

Completed

Stress Management Program for World Trade Center (WTC) Responders

PTSD | Signs and Symptoms, Respiratory

United States
Cairo University

Unknown

Layering Technique Selection for Ultimate Aesthetics in Anterior Composites

Poor Aesthetics of Existing Restoration
Stony Brook University
Northwell Health; Department of Health and Human Services; Rutgers University

Completed

The Efficacy of a Brief Resilience Training Program for Hurricane Sandy Disaster Responders

Psychological Stress
Cancer Institute and Hospital, Chinese Academy...

Unknown

Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer

Lung Neoplasm

China
Florida International University

Completed

Measurement-based Care for Depression in Resource-Poor Settings (MBC)

Major Depression

Haiti

Search clinical trials for: poor responders

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations